CD8A and malaria: Finally, Hoffman's group has recently shown that intravenous (IV) immunization of IrSpz vaccine is very effective in inducing a high frequency of malaria-specific CD8+ T cells in the liver of nonhuman primates and mice and, furthermore, conferring protection in mice [13].